3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3092SP |
Moricizine, Serum/Plasma |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3704SP |
Phenylephrine, Serum/Plasma |
3720B |
Phenylpropanolamine, Blood |
3720SP |
Phenylpropanolamine, Serum/Plasma |
3720U |
Phenylpropanolamine, Urine |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |